ADHD drugs might lower the risk of suicidal ideation or attempts in preadolescent children with serious behavioural issues, an observational study suggests.  

The benefits of early ADHD diagnosis and treatment might go beyond improved learning and behavioural outcomes, US researchers say.

The team drew on data from almost 12,000 children participating in the Adolescent Brain Cognitive Development Study, finding a link between ADHD pharmacotherapy and reduced suicidality that was most marked among the children with the greatest symptom burden.

Among the cohort (mean age nine years and nine months), some 1006 were taking medication such as methylphenidate, amphetamine derivatives, alpha-2-agonists or atomoxetine for ADHD, and 1040 reported they had contemplated or attempted suicide (58% boys, 42% girls).